Photo: Ida Marie Odgaard / Ritzau Scanpix via AFP
The World Health Organization has released its first guidelines on the Ozempic-type drugs, conditionally recommending their use for long-term treatment of obesity.
To tackle what it said was a serious health challenge, its guidelines said Glucagon-Like Peptide-1 (GLP-1) medications such as Ozempic or Wegovy could be used by adults as part of a comprehensive approach.
Continue Reading on RNZ
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.